insights_auto
Why is AGIO down 4,03%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
27,60 US$
arrow_downward
-4,03%(-1,16) 1D
27,60 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
28,01 US$
High
29,14 US$
Low
27,43 US$
Mkt. cap
1,65 მლრდ.
Avg. vol.
1,13 მლნ.
Volume
776,20 ათ.
52-wk high
44,07 US$
52-wk low
23,02 US$
EPS
-6,32 US$
Beta
0,66
Shares outstanding
59,81 მლნ.
No. of employees
540
Open
28,01 US$
High
29,14 US$
Low
27,43 US$
Mkt. cap
1,65 მლრდ.
Avg. vol.
1,13 მლნ.
Volume
776,20 ათ.
52-wk high
44,07 US$
52-wk low
23,02 US$
EPS
-6,32 US$
Beta
0,66
Shares outstanding
59,81 მლნ.
No. of employees
540
News stories
From web sources and news partners
The Motley Fool
·
1 საათის წინ
If the S&P 500 Drops by 20%, I'm Buying These 3 ETFs Without Hesitation
Traders Union
·
1 საათის წინ
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
24/7 Wall St.
·
1 საათის წინ
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
TradingView
·
4 საათის წინ
Stock Market Crash: Nasdaq, S&P 500 Suffer Worst Weekly Losses in Years
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc